Table 3 Predictors of virologic failure (HBV viral load ≥ 69 IU/mL) after 12 months of antiviral treatment, Addis Ababa, Ethiopia

Sex

 Women

44 (23.3)

5 (17.9)

1

 Men

145 (76.7)

23 (82.1)

1.52 (0.54–4.26)

0.426

Age, years (per 1-year increment)

35 (26–41)^a

35 (26–41) ^a

1.00 (0.96–1.04)

0.952

Decompensated liver disease

 No

126 (66.7)

20 (71.4)

1

 Yes

63 (33.3)

8 (28.6)

0.77 (0.32–1.86)

0.563

HBV viral load, IU/mL^b

 ≤ 10⁶

116 (62.0)

12 (42.9)

1

1

 > 10⁶

71 (38.0)

16 (57.1)

2.52 (1.11–5.71)

0.026

2.41 (1.04–5.55)

0.039

Adherence^c

 ≥ 95%

160 (85.1)

19 (67.9)

1

1

 < 95%

28 (14.9)

9 (32.1)

3.74 (1.47–9.49)

0.006

3.43 (1.33–8.88)

0.011